Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over the past six months, topping the S&P 500 by 7.4 percentage points.

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Acadia Healthcare's (ACHC) operational turnaround is advancing, with new facilities opening on sched

Here is how Absci Corporation (ABSI) and Acadia Healthcare (ACHC) have performed compared to their sector so far this year.

In the past week, Acadia Healthcare Company, Inc. reported second-quarter 2026 results showing US$865.84 million in sales and a decline in net income to US$10.93 million, while also slightly lifting full-year 2026 revenue guidance to a range of US$3.40 billion to US$3.45 billion. Despite flat year-on-year quarterly revenue and higher liability reserves, the company beat consensus earnings forecasts, generated strong free cash flow, and raised its full-year adjusted EPS outlook, supported by...

Acadia Healthcare Company has had a strong year so far, with the share price up 91.4% year to date, while the valuation checks still suggest the stock leans cheap on most measures. The 91.4% year to date gain raises the question of whether recent optimism already captures most of the good news in the price. For a behavioral health operator like Acadia Healthcare Company, expectations for sustainable patient volumes can support the current valuation. However, any pressure on reimbursement...

Shares of behavioral health company Acadia Healthcare (NASDAQ:ACHC) fell 13.3% in the afternoon session after the company reported mixed second-quarter results that overshadowed beats on headline numbers.

Acadia Healthcare Co Inc (ACHC) surpasses revenue guidance and reduces debt, while facing flat revenue growth and increased liability reserves.

Acadia Healthcare (NASDAQ:ACHC) reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation. Revenue totaled $866 million, unchanged from the prior-year quart

ACHC beats Q2 earnings and revenue estimates as admissions rise and residential treatment grow, prompting higher 2026 guidance despite profit pressure.

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +15.15% and +2.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Behavioral health company Acadia Healthcare (NASDAQ:ACHC) announced better-than-expected revenue in Q2 CY2026, but sales were flat year on year at $865.8 million. The company expects the full year’s revenue to be around $3.43 billion, close to analysts’ estimates. Its non-GAAP profit of $0.38 per share was 9.7% above analysts’ consensus estimates.

Behavioral health company Acadia Healthcare (NASDAQ:ACHC) will be announcing earnings results this Tuesday after the bell. Here’s what you need to know.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.